Sarah Strand , PhD 1 , William Lutter , PhD 1 , Janette F. Strasburger , MD 2 , Vishal Shah , PhD 3 , Oswaldo Baffa , PhD 4 , Ronald T. Wakai , PhD , 1
09 August 2019
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
magnetocardiography, arrhythmia, electrophysiology, fetal heart, long QT syndrome, Electrophysiology, Sudden Cardiac Death, Arrhythmias, Diagnostic Testing, Electrocardiology (ECG)
Fetal magnetocardiography ( fMCG) is a highly effective technique for evaluation of fetuses with life‐threatening arrhythmia, but its dissemination has been constrained by the high cost and complexity of Superconducting Quantum Interference Device (SQUID) instrumentation. Optically pumped magnetometers ( OPMs) are a promising new technology that can replace SQUIDs for many applications. This study compares the performance of an fMCG system, utilizing OPMs operating in a person‐sized magnetic shield, to that of a conventional fMCG system, utilizing SQUID magnetometers operating in a magnetically shielded room.
fMCG recordings were made in 24 subjects using the SQUID system with the mother lying supine in a magnetically shielded room and the OPM system with the mother lying prone in a person‐sized, cylindrical shield. Signal‐to‐noise ratios of the OPM and SQUID recordings were not statistically different and were adequate for diagnostic purposes with both technologies. Although the environmental noise was higher using the small open‐ended shield, this was offset by the higher signal amplitude achieved with prone positioning, which reduced the distance between the fetus and sensors and improved patient comfort. In several subjects, fMCG provided a differential diagnosis that was more precise and/or definitive than was possible with echocardiography alone.
The OPM‐based system was portable, improved patient comfort, and performed as well as the SQUID‐based system at a small fraction of the cost. Electrophysiological assessment of fetal rhythm is now practical and will have a major impact on management of fetuses with long QT syndrome and other life‐threatening arrhythmias.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.